NeonMind Biosciences Inc. announced the appointment of Dr. Dinesh Bhayana, MD, CCFP (EM), as the Site Medical Director of its recently announced inaugural specialty clinic for interventional psychiatry, located in Mississauga, Ontario. Dr. Bhayana is the Chief Medical Officer of the Centre for Compassionate Care (C3), which offers specialized psychological services including Integrative Ketamine-Enhanced Psychotherapy, served as a Board Member for the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada, and an Emergency and Addiction Medicine physician in several communities within the Greater Toronto Area. NeonMind and Dr. Bhayana will work closely with medical leaders in NeonMind's Specialty Clinics Advisory Board to set up the Company's inaugural NeonMind specialty mental health clinic in Mississauga and leverage their clinical experience to meet regulatory licensing requirements and initiate treatment services this year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.025 CAD | 0.00% |
|
-16.67% | -54.55% |
Jun. 17 | Miguel Paucar Joins Lancaster Resources Inc.'s Advisory Board | CI |
Jun. 04 | Lancaster Resources Inc. Appoints Paola Rojas as Member of its Advisory Board | CI |
1st Jan change | Capi. | |
---|---|---|
-54.55% | 1.02M | |
+28.10% | 85.24B | |
+16.42% | 71.19B | |
-.--% | 28.7B | |
+44.20% | 9.7B | |
+8.04% | 9.03B | |
+18.84% | 8.69B | |
0.00% | 7.42B | |
+26.63% | 5.93B | |
-38.36% | 5.66B |
- Stock Market
- Equities
- LCR Stock
- News Lancaster Resources Inc.
- NeonMind Biosciences Inc. Appoints Dinesh Bhayana as Site Medical Director of Its Inaugural Specialty Mental Health Clinic